Atlas Trials

Study of CT071 Injection in RRMM or PPCL

Clinical trial NCT05838131 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05838131
Sponsor
Shanghai Changzheng Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Multiple MyelomaPrimary Plasma Cell Leukemia
Start date
2023-04-28
Primary completion
2025-07-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.